People News

Share this article:
Johnson & Johnson added Anne Mulcahy, chairman of the board of Xerox, to its board. Mulcalhy spent eight years as CEO of Xerox, retiring last July.

Peregrine Pharmaceuticals hired Dr. Robert Garnick as head of regulatory affairs. Dr. Garnick was formerly senior vice president for regulatory, quality and compliance at Genentech. During his 24-year career at Genentech, he was responsible for 17 new product approvals, including most of the company's top selling monoclonal antibody therapeutics such as Rituxan, Herceptin, Avastin and Lucentis.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in People Moves

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters